×
About 571 results

ALLMedicine™ Heart-lung Transplantation Center

Research & Reviews  285 results

Non-in Situ Technique of Heart-lung Transplantation: Case Series and Technique Descript...
https://doi.org/10.1016/j.athoracsur.2021.03.101
The Annals of Thoracic Surgery; Xu X, Shi J et. al.

Apr 26th, 2021 - Heart-lung transplantation (HLTx) is a life-saving treatment option for patients with advanced cardiopulmonary failure. However, posterior mediastinal bleeding and phrenic nerve damage are still intraoperative challenges for the traditional surgic...

Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the i...
https://doi.org/10.1016/j.healun.2021.03.013
The Journal of Heart and Lung Transplantation : the Offic... Jérôme LP, Séverine F et. al.

Apr 14th, 2021 - Pulmonary arterial hypertension (PAH) is rare but remains fatal in infants and children despite the advance of targeted therapies. Lung transplantation (LTx), first performed in pediatric patients in the 1980s, is, with the Potts shunt, the only p...

Transplantation for Pulmonary Arterial Hypertension with Congenital Heart Disease: Impa...
https://doi.org/10.1111/ajt.16600
American Journal of Transplantation : Official Journal Of... Hascoët S, Pontailler M et. al.

Apr 12th, 2021 - Patients with end-stage pulmonary arterial hypertension due to congenital heart disease have limited access to heart-lung transplantation or double-lung transplantation. We aimed to assess the effects of a high-priority allocation program establis...

Long-term veno-arterial extracorporeal membrane oxygenation as a bridge to heart-lung t...
https://doi.org/10.1111/jocs.15369
Journal of Cardiac Surgery; Trezzi M, Brancaccio G et. al.

Jan 27th, 2021 - En bloc heart-lung transplantation still represents definitive therapy for end-stage cardiopulmonary failure. However, patients may critically decompensate while awaiting suitable donor organs and necessitate veno-arterial extracorporeal membrane ...

Lung transplantation for sarcoidosis: outcome and prognostic factors.
https://doi.org/10.1183/13993003.03358-2020
The European Respiratory Journal; Le Pavec J, Valeyre D et. al.

Jan 22nd, 2021 - In patients with sarcoidosis, past and ongoing immunosuppressive regimens, recurrent disease in the transplant, and extrapulmonary involvement may affect outcomes of lung transplantation. We asked whether sarcoidosis lung phenotypes can be differe...

see more →

Clinicaltrials.gov  285 results

Non-in Situ Technique of Heart-lung Transplantation: Case Series and Technique Descript...
https://doi.org/10.1016/j.athoracsur.2021.03.101
The Annals of Thoracic Surgery; Xu X, Shi J et. al.

Apr 26th, 2021 - Heart-lung transplantation (HLTx) is a life-saving treatment option for patients with advanced cardiopulmonary failure. However, posterior mediastinal bleeding and phrenic nerve damage are still intraoperative challenges for the traditional surgic...

Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the i...
https://doi.org/10.1016/j.healun.2021.03.013
The Journal of Heart and Lung Transplantation : the Offic... Jérôme LP, Séverine F et. al.

Apr 14th, 2021 - Pulmonary arterial hypertension (PAH) is rare but remains fatal in infants and children despite the advance of targeted therapies. Lung transplantation (LTx), first performed in pediatric patients in the 1980s, is, with the Potts shunt, the only p...

Transplantation for Pulmonary Arterial Hypertension with Congenital Heart Disease: Impa...
https://doi.org/10.1111/ajt.16600
American Journal of Transplantation : Official Journal Of... Hascoët S, Pontailler M et. al.

Apr 12th, 2021 - Patients with end-stage pulmonary arterial hypertension due to congenital heart disease have limited access to heart-lung transplantation or double-lung transplantation. We aimed to assess the effects of a high-priority allocation program establis...

Long-term veno-arterial extracorporeal membrane oxygenation as a bridge to heart-lung t...
https://doi.org/10.1111/jocs.15369
Journal of Cardiac Surgery; Trezzi M, Brancaccio G et. al.

Jan 27th, 2021 - En bloc heart-lung transplantation still represents definitive therapy for end-stage cardiopulmonary failure. However, patients may critically decompensate while awaiting suitable donor organs and necessitate veno-arterial extracorporeal membrane ...

Lung transplantation for sarcoidosis: outcome and prognostic factors.
https://doi.org/10.1183/13993003.03358-2020
The European Respiratory Journal; Le Pavec J, Valeyre D et. al.

Jan 22nd, 2021 - In patients with sarcoidosis, past and ongoing immunosuppressive regimens, recurrent disease in the transplant, and extrapulmonary involvement may affect outcomes of lung transplantation. We asked whether sarcoidosis lung phenotypes can be differe...

see more →